EE152 Cost-Effectiveness Analysis of Infliximab Versus Cyclosporine in Steroid-Refractory Acute Severe Ulcerative Colitis
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.451
https://www.valueinhealthjournal.com/article/S1098-3015(24)00566-7/fulltext
Title :
EE152 Cost-Effectiveness Analysis of Infliximab Versus Cyclosporine in Steroid-Refractory Acute Severe Ulcerative Colitis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00566-7&doi=10.1016/j.jval.2024.03.451
First page :
Section Title :
Open access? :
No
Section Order :
11794